Sisheng
Hu
a,
Liang
Lu
a,
Tongyang
Zhu
a,
Qian
Wu
b,
Ying
Chen
b,
Jie Jack
Li
*c and
Jing
Zhao
*ab
aState Key Laboratory of Pharmaceutical Biotechnology, School of Chemistry and Chemical Engineering, Institute of Chemistry and BioMedical Sciences, Nanjing University, Nanjing, 210093, China. E-mail: jingzhao@nju.edu.cn
bGuangdong Key Lab of Nano-Micro Material Research, School of Chemical Biology and Biotechnology, Shenzhen Graduate School of Peking University, Shenzhen, 518055, China
cDepartment of Chemistry, University of San Francisco, San Francisco, CA 94117, USA
First published on 28th November 2017
A Rh(III)-catalyzed C–H alkynylation of substituted N-phenoxyacetamides has been developed with the aid of hypervalent iodine-alkyne reagents. Complementary to the Sonogashira coupling reaction, this protocol provides an efficient and straightforward method to access aryl alkynes at room temperature. The multifunctional directing group is preserved which can be further employed for ortho-directed functionalizations to obtain additional new complex products.
Being cognizant of the high reactivity of hypervalent iodine reagents,5 we commenced our studies using 1-[(triisopropylsilyl)ethynyl]-1,2-benziodoxol-3(1H)-one 2a (TIPS-EBX) as the coupling partner. When 2-methyl N-phenoxyacetamide 1a was treated with partner 2a using [Cp*RhCl2]2 (2.5 mol%) as the catalyst and CsOAc (0.3 equiv.) as the base in DCM at room temperature under a N2 atmosphere for 5 h (Table 1, entry 1), 3a was obtained as the major product in good yield. The structure of 3a was proved to be that of the desired ortho-alkynylated product which was different from our previous work where the O–N bond of the oxyacetamide group was preserved. In most of our previous studies, the O–NHAc group played multiple roles while the O–N bond, as an internal oxidant, was broken along with the interaction with the catalyst.6c–e In contrast, the O–N bond was also observed to be preserved in the final products under several conditions.6a,b
Entry | Base (equiv.) | Solvent | Yield (NMR) |
---|---|---|---|
a Conditions: 1a (0.1 mmol), 2a (0.12 mmol), [Cp*RhCl2]2 (2.5 mol%), and base in solvent (0.5 mL) at room temperature for 5 h under N2. Crude yield, as determined by 1H NMR spectroscopy using 1,4-dimethoxybenzene as an internal standard. | |||
1 | CsOAc (0.3) | DCM | 70% |
2 | CsOAc (0.3) | DCE | 69% |
3 | CsOAc (0.3) | CH3CN | 69% |
4 | CsOAc (0.3) | Toluene | 70% |
5 | CsOAc (0.3) | THF | 84% |
6 | CsOAc (0.3) | 1,4-Dioxane | 85% |
7 | CsOAc (0.3) | MeOH | 95% |
8 | CsOAc (0.3) | EtOH | 78% |
9 | CsOAc (0.3) | Isopropanol | 74% |
10 | CsOAc (0.3) | t-BuOH | 78% |
11 | AgOAc (0.3) | MeOH | 74% |
12 | NaOAc (0.3) | MeOH | 76% |
13 | Cs2CO3 (0.3) | MeOH | 82% |
14 | Ag2CO3 (0.3) | MeOH | 73% |
15 | Na2CO3 (0.3) | MeOH | 76% |
16 | K2CO3 (0.3) | MeOH | 73% |
17 | CsOAc (0.5) | MeOH | 90% |
18 | CsOAc (1) | MeOH | 89% |
Other solvents were also screened and MeOH dramatically enhanced the yield to 95% (Table 1, entries 1–10). We also examined different bases and found CsOAc to be the most effective (Table 1, entries 11–16). But increasing the equivalence of CsOAc did not significantly boost the yields (Table 1, entries 17 and 18). Finally, we set the standard reaction conditions to be [Cp*RhCl2]2 (2.5 mol%) and CsOAc (0.3 equiv.) in MeOH under nitrogen at room temperature.
With the optimized conditions in hand, we proceeded to explore the scope of N-phenoxyacetamides (Table 2). N-Phenoxyacetamides bearing electron-donating groups such as methyl (1a, 1b, 1c,), tert-butyl (1d), and dimethyl (1f) and electron-withdrawing groups such as halides (1h–1m) and ester (1n) all proceeded smoothly to afford the corresponding products in moderate to high yields ranging from 77% to 95%. When non-, meta- or para-substituted N-phenoxyacetamides reacted with 1.2 equiv. of TIPS-EBX, the dialkynylation products were obtained as the major products. Therefore, when 4 equiv. of N-phenoxyacetamides were used, the mono-alkynylation products were isolated in excellent yields. In this case, the reaction occurred at the less-hindered position when the meta-position of N-phenoxyacetamides (1h, 1j, 1l) was occupied. This regioselectivity showcased the importance of the steric effect in this reaction. In addition, we also examined the substituents on the nitrogen atom of N-phenoxyacetamides. When substrate 1o containing two competitive directing groups was used, the reaction took place regiospecifically at the position ortho to the oxyamine directing group, affording product 3o in 80% yield, which was different from what was previously reported.6b,7 However, the use of the bulky tert-butyryl group instead of the acetyl group only gave 3p in a trace amount. Meanwhile, we explored the alkynylation of various hypervalent iodine-alkyne reagents containing different aryl and alkynyl substituents (2b–2d). The corresponding products were obtained in good yields (Table 3).
EBX reagent | Product | EBX reagent | Product |
---|---|---|---|
a Conditions: 1 (0.1 mmol) and 2 (0.9 mmol) were used. [{Cp*RhCl2}2] (2.5 mol%), and additives in solvent (1 mL) at room temperature for 5 h under N2. Isolated yields. | |||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
We investigated the reactivity of the obtained alkynyl N-phenoxyacetamides. Product 3f was explored as a model substrate. Treating 3f with the iridium catalyst [Cp*IrCl2]26e led to the ortho-oxidation of phenol by O–NHAc directed second C–H activation in the internal oxidation pathway (4a). The TIPS protecting group can also be removed under basic conditions (TBAF/THF) without changing the O–NHAc group (4b) (Scheme 2).
![]() | ||
Scheme 2 Derivatisation of reaction products. a![]() |
To gain a better understanding of the mechanism, we treated 1b with [Cp*RhCl2]2 (2.5 mol%) and CsOAc (0.3 equiv.) in CD3CD (Scheme 3a). After stirring at room temperature for 5 h, the reaction mixture was directly subjected to 1H NMR measurement. It was found that deuterium was incorporated exclusively at the ortho position to the directing group. This experiment indicated that the first reaction step may be a facile and reversible cyclometalation. To determine the turnover-limited step of the catalytic cycle, the kinetic isotope effect (KIE) was measured. Parallel experiments of 1b and d5-1b with TIPS-EBX gave a result as KH/KD = 1.1, indicating that the C–H bond cleavage process was unlikely involved in the rate-determining step (Scheme 3a).8 We successfully obtained the intermediate A by reacting 1f with the rhodium catalyst [Cp*RhCl2]2. Intermediate A smoothly produced the expected product 3f, suggesting that intermediate A was the active intermediate in this reaction (Scheme 3b).
On the basis of these observations and literature precedence, we proposed the following mechanism. First, the active catalyst [Cp*RhIII(OAc)2] is generated from [Cp*RhCl2]2 and CsOAc. Intermediate A is then formed via reversible C–H activation between substrate 1e and the catalyst [Cp*RhIII(OAc)2] through a concerted metalation–deprotonation (CMD) pathway. The following regioselective carborhodation of TIPS-EBX generates intermediate B. Then α-elimination occurs to produce the rhodium vinylidene C, with the release of 2-iodobenzoic acid.9 There are two kinds of possible pathways for further process, in pathway a, the species undergoes intramolecular concerted 1,2-aryl migration and breaking of the C–Rh bond to generate the intermediate E.5a,10 In pathway b, C could follow stepwise silicium group migration and elimination viaD to produce the same intermediate E. Finally, the protonation of E with another molecule HOAc will produce the desired alkynylation product 3e, and the released active catalyst will trigger the next cycle.5p,q Another probable mechanism is also considered in pathway c. The oxidative addition of TIPS-EBX to intermediate A generates Rh(V) intermediate F which undergoes reductive elimination to obtain product 3e directly (Scheme 4).
It is interesting to note that the hypervalent iodine-alkynes could act as both alkynylation agents and oxidants, which might explain the fact that the O–N bond was preserved in the final products.
Footnote |
† Electronic supplementary information (ESI) available: Experimental procedures and characterization data for all new compounds. See DOI: 10.1039/c7ob02438j |
This journal is © The Royal Society of Chemistry 2018 |